Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01206530
Title FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Bevacizumab

Hydroxychloroquine

Age Groups: adult
Covered Countries USA


No variant requirements are available.